| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Beyond Hepatoprotection—The Cardioprotective Effects of Bicyclol in Diabetes
|
Samidurai, Arun
|
|
|
38 |
3 |
p. 411-413
|
artikel
|
| 2 |
Bicyclol Alleviates Streptozotocin-induced Diabetic Cardiomyopathy By Inhibiting Chronic Inflammation And Oxidative Stress
|
Zhang, Lingxi
|
|
|
38 |
3 |
p. 555-568
|
artikel
|
| 3 |
C/EBP Homologous Protein: A Potential Therapeutic Target for Atherosclerosis Treatment?
|
Shan, Jinjiao
|
|
|
38 |
3 |
p. 415
|
artikel
|
| 4 |
Comparative Muscle Tolerability of Different Types and Intensities of Statins: A Network Meta-Analysis of Double-Blind Randomized Controlled Trials
|
Hou, Qingtao
|
|
|
38 |
3 |
p. 459-469
|
artikel
|
| 5 |
Correction to: Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis‑Related Pulmonary Hypertension
|
Lui, Justin K.
|
|
|
38 |
3 |
p. 657
|
artikel
|
| 6 |
Correction to: Prevalence and Associated Factors of Inappropriate Dosing of Direct Oral Anticoagulants In Patients With Atrial Fibrillation: The ANATOLIA-AF Study
|
Kocabaş, Umut
|
|
|
38 |
3 |
p. 601-603
|
artikel
|
| 7 |
Direct Oral Anticoagulants: Navigating Through Clinical Challenges
|
Ioannou, Maria
|
|
|
38 |
3 |
p. 637-650
|
artikel
|
| 8 |
Effect of Remote Ischaemic Conditioning on the Inflammatory Cytokine Cascade of COVID-19 (RIC in COVID-19): a Randomized Controlled Trial
|
Lukhna, Kishal
|
|
|
38 |
3 |
p. 433-445
|
artikel
|
| 9 |
Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled Trials
|
Koenig, Wolfgang
|
|
|
38 |
3 |
p. 493-503
|
artikel
|
| 10 |
Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension
|
Lui, Justin K.
|
|
|
38 |
3 |
p. 651-656
|
artikel
|
| 11 |
IL-33 in Atherosclerosis: An Insufficiently Explored and Controversial Research Area
|
Ye, Yanyan
|
|
|
38 |
3 |
p. 419-420
|
artikel
|
| 12 |
IL-33 Suppresses the Progression of Atherosclerosis via the ERK1/2-IRF1-VCAM-1 Pathway
|
Qian, Zhang
|
|
|
38 |
3 |
p. 569-580
|
artikel
|
| 13 |
Impairment of Vascular Homeostasis in Acute Heart Failure: Enter the Monocyte?
|
Liu, Saifei
|
|
|
38 |
3 |
p. 405-409
|
artikel
|
| 14 |
Influence of Genetic and Epigenetic Factors of P2Y12 Receptor on the Safety and Efficacy of Antiplatelet Drugs
|
Danielak, Dorota
|
|
|
38 |
3 |
p. 621-636
|
artikel
|
| 15 |
Instent CTO—What Is the Best Treatment Strategy?
|
Sahyouni, Mark
|
|
|
38 |
3 |
p. 393-394
|
artikel
|
| 16 |
Left Bundle Branch Area Pacing versus Biventricular Pacing for Cardiac Resynchronization Therapy on Morbidity and Mortality
|
Liang, Yixiu
|
|
|
38 |
3 |
p. 471-481
|
artikel
|
| 17 |
Left Ventricular Thrombus Management After Acute Myocardial Infarction in Clinical Practice: Results from LEVITATION Survey and Narrative Review
|
Di Odoardo, Luca A. F.
|
|
|
38 |
3 |
p. 483-492
|
artikel
|
| 18 |
MicroRNA-92a in Cardiovascular Disease: An Insufficiently Explored and Controversial Research Area
|
Cui, Jin-Zhen
|
|
|
38 |
3 |
p. 423-424
|
artikel
|
| 19 |
Mitogen-Activated Protein Kinases Mediate Adventitial Fibroblast Activation and Neointima Formation via GATA4/Cyclin D1 Axis
|
Chen, Jing
|
|
|
38 |
3 |
p. 527-538
|
artikel
|
| 20 |
Open Issues in the Management of Otcagerian Patients with Atrial Fibrillation and Chronic Kidney Disease: Are we Ready for Left Atrial Appendage Occlusion (LAAO) as First-Line Therapy for Thromboembolic Risk Prevention?
|
Condello, Francesco
|
|
|
38 |
3 |
p. 401-403
|
artikel
|
| 21 |
Poking and Prodding So They Take Their Pills
|
Reddy, Revati
|
|
|
38 |
3 |
p. 395-396
|
artikel
|
| 22 |
Possible Cardioprotective Effects of Lactate Infusion After Cardiac Arrest or Prolonged Myocardial Ischemia
|
Koyama, Takashi
|
|
|
38 |
3 |
p. 417-418
|
artikel
|
| 23 |
PrevAleNce and Associated factors of inappropriaTe dosing of direct Oral anticoaguLants In pAtients with Atrial Fibrillation: the ANATOLIA-AF Study
|
Kocabaş, Umut
|
|
|
38 |
3 |
p. 581-599
|
artikel
|
| 24 |
Promising Drug Fondaparinux for the Treatment of COVID-19: an In Silico Analysis of Low Molecular Weight Heparin, Direct Oral Anticoagulant, and Antiplatelet Drug Interactions with Host Protease Furin
|
Ertan-Bolelli, Tugba
|
|
|
38 |
3 |
p. 425-432
|
artikel
|
| 25 |
Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease
|
Lee, Wei-Chieh
|
|
|
38 |
3 |
p. 505-515
|
artikel
|
| 26 |
Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study
|
Mathew, Roy O.
|
|
|
38 |
3 |
p. 447-457
|
artikel
|
| 27 |
The Association of Proton Pump Inhibitors and QT Interval Prolongation in Critically Ill Patients
|
Fan, Weiguo
|
|
|
38 |
3 |
p. 517-525
|
artikel
|
| 28 |
The Cost of Breaking Even: a Perspective on the Net Clinical Impact of Adding Aspirin to Antithrombotic Therapies in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
|
Triska, Jeffrey
|
|
|
38 |
3 |
p. 605-619
|
artikel
|
| 29 |
The Potential Cardiovascular Benefits of COVID-19 Vaccination: Lessons from Influenza and Emerging Evidence
|
Kow, Chia Siang
|
|
|
38 |
3 |
p. 421-422
|
artikel
|
| 30 |
Vaccine Targeting Alpha 1D-Adrenergic Receptor Improved Metabolic Syndrome in Mice
|
Li, Xin
|
|
|
38 |
3 |
p. 539-554
|
artikel
|
| 31 |
When Less is More: Drug-Coated Balloons Threaten a Paradigm Revolution
|
Alqam, Bilal
|
|
|
38 |
3 |
p. 397-399
|
artikel
|
Tijdschrift beschrijving